Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03338452
Other study ID # LEKD2017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 18, 2017
Est. completion date June 24, 2018

Study information

Verified date October 2018
Source University of Primorska
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study evaluates the timeline of changes of body composition, physical and psychological performance, and biochemical markers of metabolism and inflammation responses to low energy ketogenic diet for loosing weight in obese individuals. The participants will be monitored and guided by the interdisciplinary obesity team for 12 weeks.


Description:

Ketogenic diets have been shown to be an effective tool to fight obesity with reported good adherence due to their ability to suppress the drive to eat. They are also gaining popularity in public, despite some concerns regarding the quality and timeline of changes of body composition and the effects on health parameters of whole organism.

For effective weight loss, energy deficit is required. Very low energy (600 - 800 kcal) ketogenic diets have been extensively studied.

The proposed study combines low energy (800 - 1500 kcal) and ketogenic diet intervention. The aim of the study is a comprehensive determination of quality of body mass loss, metabolic states changes, physical and psychological performance changes, and inflammatory and hormones profile changes during and post a 12-week low energy ketogenic diet intervention.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date June 24, 2018
Est. primary completion date June 17, 2017
Accepts healthy volunteers No
Gender All
Age group 25 Years to 55 Years
Eligibility Inclusion Criteria:

- BMI > 30 kg/m2

- asymptomatic for any disease except obesity

Exclusion Criteria:

- presence of cardiovascular, endocrine, acute or chronic inflammatory diseases;

- taking medications for lipid metabolism, or psychiatric disorders;

- adherence to a prescribed diet;

- unstable weight in the past 3 months;

- BMI < 30 kg/m2;

- unwilling or unable to eat the foods prescribed in the study;

- vigorous physical activity;

- pregnancy or lactation.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Low energy ketogenic diet
Low energy ketogenic diet lasting 12 weeks with a previous preparation period including detailed instructions during classes and individual counselling by a dietitian. Participants were provided with a list of suitable foods with very low carbohydrate content. Furthermore, the subjects shared cooking recipes and links to helpful webpages. They were free to follow a KD according to their personal preferences but limit their carbohydrate intake to 5-10 % of total energy from carbohydrates, but derive at least 70 % of total energy from fat.

Locations

Country Name City State
Slovenia University of Primorska, Faculty of Health Sciences Izola

Sponsors (1)

Lead Sponsor Collaborator
University of Primorska

Country where clinical trial is conducted

Slovenia, 

References & Publications (4)

Noakes TD, Windt J. Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review. Br J Sports Med. 2017 Jan;51(2):133-139. doi: 10.1136/bjsports-2016-096491. Review. — View Citation

Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int. 2014;2014:474296. doi: 10.1155/2014/474296. Epub 2014 Jul 3. Review. — View Citation

Urbain P, Strom L, Morawski L, Wehrle A, Deibert P, Bertz H. Impact of a 6-week non-energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in healthy adults. Nutr Metab (Lond). 2017 Feb 20;14:17. doi: 10.1186/s12986-017-0175-5. eCollection 2017. — View Citation

Yang MU, Van Itallie TB. Composition of weight lost during short-term weight reduction. Metabolic responses of obese subjects to starvation and low-calorie ketogenic and nonketogenic diets. J Clin Invest. 1976 Sep;58(3):722-30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body composition Body mass, fat free body mass and fat mass will be measured (all in kilograms) with bioelectrical impedance analysis (BIA) Tanita BC 418MA. Change from baseline over 12 weeks with intermediate time points at 1, 2, 4 and 8 weeks.
Primary Change in beta-hydroxybutirate Overnight fasted serum beta-hydroxybutirate will be determined (in mmol/l). Change from baseline over 12 weeks with intermediate time points at 1, 2, 4 and 8 weeks.
Primary Change in resting energy rate Resting energy rate will be determined with indirect calorimetry. Change from baseline to 12 weeks.
Primary Change in physical fitness Physical fitness will be determined using 2 km walking test according to the UKK Walk Test Programme. Change from baseline to 12 weeks.
Primary Change in cognitive functions Will be assessed by validated psychological test (Wechsler Adult Intelligence Scale - Forth Edition (WAIS-IV). Change from baseline to 12 weeks.
Primary Change in psychological factors Will be assessed by validated psychological test (Dutch Eating Behavior Questionnaire (DEBQ). Change from baseline to 12 weeks.
Secondary Change in body weight following intervention Maintenance of body mass at the end of intervention will be evaluated over the 12 months following intervention (in kilogrames). Change from 12 weeks to 12 months.
Secondary Adherence to ketogenic diet Adherence to ketogenic diet will be assessed by 3-day food record. At 12 months.
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2